Localized magnetic plasmons in all-dielectric mu<0 metastructures

Metamaterials are known to exhibit a variety of electromagnetic properties non-existing in nature. We show that an all-dielectric (non-magnetic) system consisting of deep subwavelength, high permittivity resonant spheres possess effective negative magnetic permeability (dielectric permittivity being positive and small). Due to the symmetry of the electromagnetic wave equations in classical electrodynamics, localized "magnetic" plasmon resonances can be excited in a metasphere made of such metamaterial. This is theoretically demonstrated by the coupled-dipole approximation and numerically for real spheres, in full agreement with the exact analytical solution for the scattering process by the same metasphere with effective material properties predicted by effective medium theory. The emergence of this phenomenon as a function of structural order within the metastructures is also studied. Universal conditions enabling effective negative magnetic permeability relate subwavelength sphere permittivity and size with critical filling fraction. Our proposal paves the way towards (all-dielectric) magnetic plasmonics, with a wealth of fascinating applications.Comment: 7 pages, 4 figures; figure 3 modified and new figure (4) added, with corresponding discussio

Microscopic Theory of Scattering of Weak Electromagnetic Radiation by a Dense Ensemble of Ultracold Atoms

Based on the developed quantum microscopic theory, the interaction of weak electromagnetic radiation with dense ultracold atomic clouds is described in detail. The differential and total cooperative scattering cross sections are calculated for monochromatic radiation as particular examples of application of the general theory. The angular, spectral, and polarization properties of scattered light are determined. The dependence of these quantities on the sample size and concentration of atoms is studied and the influence of collective effects is analyzed

Electric and magnetic dipolar response of small dielectric particles: Scattering anisotropy and optical forces

We predict that real small dielectric particles made of non-magnetic materials present non-conventional scattering properties similar to those previously reported for somewhat hypothetical magnetodielectric particles

Ezetimibe added to statin therapy after acute coronary syndromes

BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known. METHODS: We conducted a double-blind, randomized trial involving 18,144 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and had LDL cholesterol levels of 50 to 100 mg per deciliter (1.3 to 2.6 mmol per liter) if they were receiving lipid-lowering therapy or 50 to 125 mg per deciliter (1.3 to 3.2 mmol per liter) if they were not receiving lipid-lowering therapy. The combination of simvastatin (40 mg) and ezetimibe (10 mg) (simvastatin-ezetimibe) was compared with simvastatin (40 mg) and placebo (simvastatin monotherapy). The primary end point was a composite of cardiovascular death, nonfatal myocardial infarction, unstable angina requiring rehospitalization, coronary revascularization ( 6530 days after randomization), or nonfatal stroke. The median follow-up was 6 years. RESULTS: The median time-weighted average LDL cholesterol level during the study was 53.7 mg per deciliter (1.4 mmol per liter) in the simvastatin-ezetimibe group, as compared with 69.5 mg per deciliter (1.8 mmol per liter) in the simvastatin-monotherapy group (P<0.001). The Kaplan-Meier event rate for the primary end point at 7 years was 32.7% in the simvastatin-ezetimibe group, as compared with 34.7% in the simvastatin-monotherapy group (absolute risk difference, 2.0 percentage points; hazard ratio, 0.936; 95% confidence interval, 0.89 to 0.99; P = 0.016). Rates of pre-specified muscle, gallbladder, and hepatic adverse effects and cancer were similar in the two groups. CONCLUSIONS: When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit